Lactobacillus reuteri probiotic lozenge
Term · Oncology and biomedicine · MLC-T-ONC-014698
An oral lozenge containing the DSM 17938 and ATCC PTA 5289 strains of the probiotic Gram-positive, naturally occurring bacterium Lactobacillus reuteri (L. reuteri), with potential antimicrobial, immunomodulatory and protective activities. Upon oral administration of L. reuteri probiotic lozenge, the Lactobacillus strain may modulate the composition of the oral biofilm, which may inhibit the colonization and recolonization of pathogens. It may also downregulate proinflammatory cytokines and reduce inflammation.
| Identifier | MLC-T-ONC-014698 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | L. reuteri probiotic lozenge |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014698",
"term": "Lactobacillus reuteri probiotic lozenge",
"field": "Oncology and biomedicine",
"definition": "An oral lozenge containing the DSM 17938 and ATCC PTA 5289 strains of the probiotic Gram-positive, naturally occurring bacterium Lactobacillus reuteri (L. reuteri), with potential antimicrobial, immunomodulatory and protective activities. Upon oral administration of L. reuteri probiotic lozenge, the Lactobacillus strain may modulate the composition of the oral biofilm, which may inhibit the colonization and recolonization of pathogens. It may also downregulate proinflammatory cytokines and reduce inflammation.",
"synonyms": [
"L. reuteri probiotic lozenge"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/lactobacillus-reuteri-probiotic-lozenge/"
}
Record 9,882 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.